A Randomized, Phase 3, Double-Blind Study of Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical Cancer
Trial Number
NCT04221945 (ClinicalTrials.gov Identifier)Contact Person
Status
Recruiting
Disease Site
Cervical
Lead Cooperative Group
Participating Groups
CTI
CEEGOG
BGOG
DGOG
GEICO
ISGO
MaNGO
NCRI
NOGGO
NSGO-CTU
AGO-AUST